For example, genes like APOD, ACKR1, and SFRP4 have been recognized as significant in cervical cancer, and our analysis supports their involvement in tumor progression and patient survival, thereby reinforcing their potential as biomarkers in clinical practice. This evidence concerns the gene APOD and neoplasm.